Business Description
Virpax Pharmaceuticals Inc
NAICS : 541714
SIC : 2833
ISIN : US9282513053
Share Class Description:
VRPX: Ordinary SharesDescription
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.69 | |||||
9-Day RSI | 7.08 | |||||
14-Day RSI | 18.15 | |||||
3-1 Month Momentum % | 2120 | |||||
12-1 Month Momentum % | 0.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:VRPX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Virpax Pharmaceuticals Inc Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -128.943 | ||
| Beta | -76.5592 | ||
| 3-Year Sharpe Ratio | 0.55 | ||
| 3-Year Sortino Ratio | 25.57 | ||
| Volatility % | 11015.02 | ||
| 14-Day RSI | 18.15 | ||
| 14-Day ATR ($) | 0.000583 | ||
| 20-Day SMA ($) | 0.005645 | ||
| 12-1 Month Momentum % | 0.91 | ||
| 52-Week Range ($) | 0.0001 - 0.1 | ||
| Shares Outstanding (Mil) | 1.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Virpax Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Virpax Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-16 | In 107 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 13 days | ||
| Annual report for 2025 | 2026-08-04 | In 3 days | ||
| General meeting for 2025 | 2026-08-03 | In 2 days | ||
| 0.04:1 Stock Split | 2025-03-21 | 2.50 (+2.88%) | ||
| Annual report for 2024 | 2025-03-03 | 6.00 (-9.43%) | ||
| Third quarter earnings results for 2024 | 2024-11-14 | 15.50 (+8.79%) | ||
| Second quarter earnings results for 2024 | 2024-08-12 | 27.25 (+9.00%) | ||
| 0.1:1 Stock Split | 2024-03-01 | 76.30 (-2.09%) |
Show
Entries
Virpax Pharmaceuticals Inc Frequently Asked Questions
What is Virpax Pharmaceuticals Inc(VRPX)'s stock price today?
The current price of VRPX is $0.00. The 52 week high of VRPX is $0.10 and 52 week low is $0.00.
When is next earnings date of Virpax Pharmaceuticals Inc(VRPX)?
The next earnings date of Virpax Pharmaceuticals Inc(VRPX) is 2026-08-14 Est..
Does Virpax Pharmaceuticals Inc(VRPX) pay dividends? If so, how much?
Virpax Pharmaceuticals Inc(VRPX) does not pay dividend.
Guru Commentaries on OTCPK:VRPX
No articles.
Press Release
Articles on Virpax Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers